<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Next-Generation Sequencing Analysis of Cellular Response to Influenza B Virus" exact="Infection" post="ShengZizhang1†*HuangChen2†LiuRunxia2†GuoYicheng1RanZhiguang2LiFeng2https://orcid.org/0000-0002-7263-8420WangDan2*[1], yg2521@cumc.columbia.edu[2], Chen.Huang@sdstate.eduRunxia.Liu@sdstate.eduFeng.Li@sdstate.edu *Correspondence: zs2248@columbia.edu (Z.S.); dan.wang@sdstate.edu (D.W.); Tel.:"/>
 <result pre="BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza B virus (IBV) is a" exact="respiratory" post="pathogen that infects humans and causes seasonal influenza epidemics."/>
 <result pre="and causes seasonal influenza epidemics. However, cellular response to IBV" exact="infection" post="in humans and mechanisms of host-mediated restriction of IBV"/>
 <result pre="sequencing (NGS) to perform transcriptome profiling of IBV-infected human lung" exact="epithelial" post="A549 cells at 0, 6, 12, and 24 h"/>
 <result pre="A549 cells at 0, 6, 12, and 24 h post" exact="infection" post="(hpi) and characterized the cellular gene expression dynamics. We"/>
 <result pre="initial insights into the intimate interaction between IBV and lung" exact="epithelial" post="cells, which can be further explored towards elucidation of"/>
 <result pre="of the cellular mechanisms in restriction or elimination of IBV" exact="infections" post="in humans. Influenza B virus innate immune response RNA-Seq"/>
 <result pre="infections in humans. Influenza B virus innate immune response RNA-Seq" exact="infection" post="1. Introduction Influenza viruses are classified as types A,"/>
 <result pre="a new type of influenza virus with bovine as a" exact="primary" post="reservoir, officially designated influenza type D, has been described"/>
 <result pre="virus with bovine as a primary reservoir, officially designated influenza" exact="type D," post="has been described [2,3]. Among these influenza viruses, only"/>
 <result pre="importance. It has been well established that humans are the" exact="primary" post="host and reservoir of IBV [4,5,6,7], although sporadic infection"/>
 <result pre="the primary host and reservoir of IBV [4,5,6,7], although sporadic" exact="infection" post="episodes of IBVs have been described in seals and"/>
 <result pre="including humans, swine, and migratory or domestic waterfowl [1]. IBV" exact="infection" post="of humans can result in the same spectrum of"/>
 <result pre="of humans can result in the same spectrum of clinical" exact="disease" post="as IAV, ranging from mild to severe respiratory illness"/>
 <result pre="of clinical disease as IAV, ranging from mild to severe" exact="respiratory" post="illness requiring immediate hospitalization and medical treatment [7,10]. IBV-associated"/>
 <result pre="coupled with the increasing strong links between IBV and fatal" exact="infections" post="in humans [21,22], calls for an urgent need for"/>
 <result pre="significant progress on the characterization of host responses to IAV" exact="infections" post="in a range of in vitro cell cultures and"/>
 <result pre="cultures and in vivo animal models, the interplay between IBV" exact="infection" post="and host cells especially human epithelial cells remains poorly"/>
 <result pre="the interplay between IBV infection and host cells especially human" exact="epithelial" post="cells remains poorly understood. A high-resolution analysis of dynamic"/>
 <result pre="high-resolution analysis of dynamic changes in cellular response following IBV" exact="infection" post="is also not available. Of many different cellular response"/>
 <result pre="innate immune response is the first line of defense against" exact="viral infection." post="The innate immune response modulates multiple pathways to signaling"/>
 <result pre="infection. The innate immune response modulates multiple pathways to signaling" exact="viral infection," post="inducing inflammatory reactions, clearing virus, and presenting viral antigens"/>
 <result pre="signaling viral infection, inducing inflammatory reactions, clearing virus, and presenting" exact="viral" post="antigens to the host immune system. It also determines"/>
 <result pre="a thorough investigation of the innate immune response to IBV" exact="infection" post="will shed light on the pathogenicity of IBV and"/>
 <result pre="severity of influenza syndromes and mechanisms of IBV resistance and" exact="disease" post="tolerance. Such studies will also further provide clues on"/>
 <result pre="further provide clues on how to interfere or prevent IBV" exact="infection" post="in humans. In this study, using next-generation sequencing (NGS)"/>
 <result pre="using next-generation sequencing (NGS) we investigated cellular response to IBV" exact="infection" post="in human lung epithelial A549 cells. Significantly, we observed"/>
 <result pre="we investigated cellular response to IBV infection in human lung" exact="epithelial" post="A549 cells. Significantly, we observed that the double-stranded RNA"/>
 <result pre="initial insights into the interactions between IBV and human lung" exact="epithelial" post="cells, which pave the way for further investigation of"/>
 <result pre="investigation of cellular mechanism in restriction or elimination of IBV" exact="infections" post="in humans. 2. Materials and Methods 2.1. Virus and"/>
 <result pre="(a gift from Robin Donis at Influenza Division, Center of" exact="Disease" post="Control and Prevention, USA). Cell lines acquired from the"/>
 <result pre="Division, Center of Disease Control and Prevention, USA). Cell lines" exact="acquired" post="from the American Type Culture Collection (ATCC, Manassas, VA,"/>
 <result pre="Disease Control and Prevention, USA). Cell lines acquired from the" exact="American" post="Type Culture Collection (ATCC, Manassas, VA, USA) for this"/>
 <result pre="Manassas, VA, USA) for this work included Human lung alveolar" exact="carcinoma" post="epithelial cell line A549 (ATCC® CCL-185) cells, Madin-Darby canine"/>
 <result pre="VA, USA) for this work included Human lung alveolar carcinoma" exact="epithelial" post="cell line A549 (ATCC® CCL-185) cells, Madin-Darby canine kidney"/>
 <result pre="to remove the cellular debris, which was followed by traditional" exact="viral" post="titration experiments in MDCK cells according to the method"/>
 <result pre="μg/mL) was used as the virus growth medium. 2.2. IBV" exact="Infection" post="of A549 Cells and Next-Generation Sequencing Influenza B/Brisbane/60/2008 virus"/>
 <result pre="to infect A549 cells at an MOI of 1.0. The" exact="viral" post="inoculum was removed after 1 h incubation from cells,"/>
 <result pre="(1 μg/mL) was added into IBV-infected cell for further cultivation." exact="Total" post="cellular RNA was isolated from mock-infected cells (0 hpi)"/>
 <result pre="University of Nebraska-Lincoln (UNL). Briefly, mRNAs were purified from the" exact="total" post="RNA using oligo(dT) magnetic beads followed by fragmentation. The"/>
 <result pre="to human genes defined by the Ensemble genome database and" exact="viral" post="genes [26]. 2.4. Differential Gene Expression Analysis DESeq was"/>
 <result pre="validate the gene expression results observed from next-generation sequencing experiment." exact="Total" post="RNA was extracted from A549 cells as 0, 6,"/>
 <result pre="the host response to IBV infection, we infected human lung" exact="epithelial" post="cells (A549) in duplicate with human IBV strain (Victoria"/>
 <result pre="with human IBV strain (Victoria lineage-B/Brisbane/60/2008) at a multiplicity of" exact="infection" post="(MOI) of 1.0 [32]. IBV replication was observed at"/>
 <result pre="highly similar but diverged between time points, suggesting that IBV" exact="infection" post="affected gene expression profiles of the host, which had"/>
 <result pre="work [32]. 3.2. Cellular Processes and Pathways Regulated by IBV" exact="Infection" post="To explore cellular responses to IBV infection, we used"/>
 <result pre="points and to identify human genes significantly regulated by IBV" exact="infection" post="(Figure 1). We then estimated enriched biological processes and"/>
 <result pre="over time. For all three time points post infection, a" exact="total" post="of 4365 genes was differentially regulated. There are more"/>
 <result pre="by pathways and processes of the innate immune response to" exact="virus infection," post="followed by responses to small molecules, antigen processing and"/>
 <result pre="than earlier time points (Figure 1b), suggesting immune response to" exact="viral infection" post="became stronger over time. Similarly, most down-regulated genes observed"/>
 <result pre="earlier time points (Figure 1b), suggesting immune response to viral" exact="infection" post="became stronger over time. Similarly, most down-regulated genes observed"/>
 <result pre="down-regulated genes at later time points were comparable to or" exact="lower" post="than earlier time points. The comparison of the enriched"/>
 <result pre="most of which are related to innate immune response to" exact="virus infection." post="We also observed that genes involved in cell cycle"/>
 <result pre="12 hpi to 24 hpi (Table 2). 3.3. Sensing IBV" exact="Infection" post="To better understand the innate immune response to IBV"/>
 <result pre="IBV infection, we analyzed regulated genes in pathways related to" exact="viral infection" post="including detection of infection, interferon and cytokine cascade, viral"/>
 <result pre="infection, we analyzed regulated genes in pathways related to viral" exact="infection" post="including detection of infection, interferon and cytokine cascade, viral"/>
 <result pre="viral infection including detection of infection, interferon and cytokine cascade," exact="viral" post="myocarditis, antigen processing and presentation, and disease tolerance (Figure"/>
 <result pre="and cytokine cascade, viral myocarditis, antigen processing and presentation, and" exact="disease" post="tolerance (Figure 3). We then verified the expression change"/>
 <result pre="conventional RT-qPCR (Figure 4). Previous studies demonstrated that influenza A" exact="virus infection" post="is mainly detected by three classes of pattern recognition"/>
 <result pre="RT-qPCR (Figure 4). Previous studies demonstrated that influenza A virus" exact="infection" post="is mainly detected by three classes of pattern recognition"/>
 <result pre="important in induction of the innate immune response to IBV" exact="infection" post="in A549 cells. Future study is needed to address"/>
 <result pre="Interferon Response RIG-I and TLR7 have been reported to activate" exact="type I" post="IFN pathway. Consistent with this, we observed that genes"/>
 <result pre="alternative mechanisms to initiate a similar immune response at the" exact="absence of" post="TLR7 molecule in A549 cells. Further analysis showed that"/>
 <result pre="pathways were activated as a function of time following IBV" exact="infection" post="(Figure 3 and Figure 4). For example, IFN-III family"/>
 <result pre="(Table S1). Future study that addresses MHC-II response to IBV" exact="infection" post="should be pursued in cell lines expressing TLR7/8 molecule."/>
 <result pre="be pursued in cell lines expressing TLR7/8 molecule. 3.8. Host" exact="Resistance" post="and Tolerance to IBV Infection Host resistance to viral"/>
 <result pre="expressing TLR7/8 molecule. 3.8. Host Resistance and Tolerance to IBV" exact="Infection" post="Host resistance to viral infection or protective host response"/>
 <result pre="Host Resistance and Tolerance to IBV Infection Host resistance to" exact="viral infection" post="or protective host response and disease tolerance play critical"/>
 <result pre="Resistance and Tolerance to IBV Infection Host resistance to viral" exact="infection" post="or protective host response and disease tolerance play critical"/>
 <result pre="Host resistance to viral infection or protective host response and" exact="disease" post="tolerance play critical roles to modulate viral pathogenicity and"/>
 <result pre="host response and disease tolerance play critical roles to modulate" exact="viral" post="pathogenicity and severity of damage to host tissues and"/>
 <result pre="damage to host tissues and organs. Previous studies on IAV" exact="infection" post="revealed that both processes are modulated by certain key"/>
 <result pre="key factors [36]. Host resistance genes improve protection via repressing" exact="viral" post="replication with multiple mechanisms, while other genes can modulate"/>
 <result pre="viral replication with multiple mechanisms, while other genes can modulate" exact="disease" post="tolerance by depressing the inflammatory reactions. To understand whether"/>
 <result pre="expression levels of reported key regulators in protecting cells from" exact="viral infection" post="[36]. Our analysis showed that many genes that are"/>
 <result pre="levels of reported key regulators in protecting cells from viral" exact="infection" post="[36]. Our analysis showed that many genes that are"/>
 <result pre="analysis showed that many genes that are important for repressing" exact="viral" post="replication and assembly were up regulated more than 100-fold"/>
 <result pre="at 24 hpi was observed (Table S1), suggesting that IBV" exact="infection" post="may induce cell cycle arrest, which as a result"/>
 <result pre="changes in this intrinsic antiviral pathway in response to IBV" exact="infection" post="is critical to elucidate IBV-host interaction. In this study,"/>
 <result pre="to elucidate IBV-host interaction. In this study, we examined IBV" exact="infection" post="induced response in human lung epithelial A549 cells, a"/>
 <result pre="study, we examined IBV infection induced response in human lung" exact="epithelial" post="A549 cells, a well characterized cell system that responds"/>
 <result pre="A549 cells, a well characterized cell system that responds to" exact="infection" post="robustly and has been extensively used to investigate innate"/>
 <result pre="to investigate innate immune response of pathogens, including but not" exact="limited" post="to Ebola virus [40], Influenza A virus [41,42,43], Aspergillus"/>
 <result pre="virus [40], Influenza A virus [41,42,43], Aspergillus fumigatus [44], Newcastle" exact="Disease" post="Virus [45]. Our results generated a number of interesting"/>
 <result pre="of interesting observations. Upon IBV infection, we observed that both" exact="type I" post="and III IFN responses were activated over time, which"/>
 <result pre="TLR-3, The activation of RIG-1 and IFN response during IBV" exact="infection" post="observed here (Figure 3 and Figure 4) is similar"/>
 <result pre="has been described in previous studies [46,47]. Furthermore, a robust" exact="type III" post="IFN response in infected-A549 cells described in this work"/>
 <result pre="by previous studies in antigen presentation cells [46,47], indicating that" exact="type III" post="IFN response may serve as one of the primary"/>
 <result pre="type III IFN response may serve as one of the" exact="primary" post="antiviral defenses against influenza infection [42]. In addition, we"/>
 <result pre="serve as one of the primary antiviral defenses against influenza" exact="infection" post="[42]. In addition, we observed no inducible expression of"/>
 <result pre="addition, we observed no inducible expression of IFN-γ, representative of" exact="type II" post="IFN response, which is in line with the fact"/>
 <result pre="of chemokines such as IL8 would recruit neutrophil to the" exact="infection" post="site. Induction of Mx1 protein expression would be expected"/>
 <result pre="in our previous work [32]. Previous studies showed that IAV" exact="infection" post="arrested A549 cells at the G0/G1 phase [49,50,51], via"/>
 <result pre="proteins. It is assumed that cell cycle arrest can benefit" exact="viral" post="replication. For instance, the transcription activity of DNA polymerase"/>
 <result pre="II (Pol II), which is required for the transcription of" exact="viral" post="proteins, is higher in G0/G1 phase than other phases."/>
 <result pre="higher in G0/G1 phase than other phases. The translation of" exact="viral" post="proteins requires host-derived cap-dependent translation activity, which is optimal"/>
 <result pre="S and M phases are down regulated, implying that IBV" exact="infection" post="may slow down cellular processes such as DNA recombination,"/>
 <result pre="showed that TLR7 and TLR8 are not expressed in human" exact="epithelial" post="A549 cells [33]. Lacking TLR7/TLR8 molecules apparently prevented us"/>
 <result pre="molecules apparently prevented us from investigating a function of these" exact="viral" post="single-stand RNA recognition receptors for detection of IBV infection."/>
 <result pre="response in infected A549 cells. Where rapid detection of IBV" exact="infection" post="by TLR3 or RIG-1 observed in A549 cells is"/>
 <result pre="or RIG-1 observed in A549 cells is applicable to other" exact="epithelial" post="cells, especially primary human epithelial cells, remains to be"/>
 <result pre="in A549 cells is applicable to other epithelial cells, especially" exact="primary" post="human epithelial cells, remains to be studied. In addition,"/>
 <result pre="cells is applicable to other epithelial cells, especially primary human" exact="epithelial" post="cells, remains to be studied. In addition, future study"/>
 <result pre="studied. In addition, future study also needs to consider employing" exact="epithelial" post="cells having a full-spectrum of innate immune activators and"/>
 <result pre="also imperative that the antiviral and cellular responses to IBV" exact="infection" post="are evaluated in antigen-presentation cells such as macrophages or"/>
 <result pre="provide novel insights into the intricate host-pathogen interaction following IBV" exact="infection" post="of human lung epithelial cells, which can be further"/>
 <result pre="the intricate host-pathogen interaction following IBV infection of human lung" exact="epithelial" post="cells, which can be further explored toward the elucidation"/>
 <result pre="the elucidation of the mechanisms by which IBV remodels the" exact="epithelial" post="environment to promote its own replication and spread in"/>
 <result pre="study; Z.S. and Y.G. analyzed the transcriptome data, R.L. performed" exact="virus infection" post="and RNA extraction; Z.R. performed the virus titration experiment;"/>
 <result pre="Z.S. and Y.G. analyzed the transcriptome data, R.L. performed virus" exact="infection" post="and RNA extraction; Z.R. performed the virus titration experiment;"/>
 <result pre="RNA extraction; Z.R. performed the virus titration experiment; C.H. performed" exact="virus infection," post="and RT-qPCR assay to quantify gene-expression; Z.S., F.L., and"/>
 <result pre="genus in the Orthomyxoviridae familyMBio20145e00031-1410.1128/mBio.00031-1424595369 3.HauseB.M.DucatezM.CollinE.A.RanZ.LiuR.ShengZ.ArmienA.KaplanB.ChakravartyS.HoppeA.D.et al.Isolation of a novel" exact="swine influenza" post="virus from Oklahoma in 2011 which is distantly related"/>
 <result pre="B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 9.RanZ.ShenH.LangY.KolbE.A.TuranN.ZhuL.MaJ.BawaB.LiuQ.LiuH.et al.Domestic pigs are susceptible to" exact="infection" post="with influenza B virusesJ. Virol.2015894818482610.1128/JVI.00059-1525673727 10.Paul GlezenW.SchmierJ.K.KuehnC.M.RyanK.J.OxfordJ.The burden of"/>
 <result pre="J. Public Health2013103e43e5110.2105/AJPH.2012.30113723327249 11.Gutierrez-PizarrayaA.Perez-RomeroP.AlvarezR.AydilloT.A.Osorio-GomezG.Milara-IbanezC.SanchezM.PachonJ.CorderoE.Unexpected severity of cases of influenza B" exact="infection" post="in patients that required hospitalization during the first postpandemic"/>
 <result pre="reexamine influenza research prioritiesJ. Infect. Dis.201220587087210.1093/infdis/jir86522291194 22.PaddockC.D.LiuL.DenisonA.M.BartlettJ.H.HolmanR.C.Deleon-CarnesM.EmeryS.L.DrewC.P.ShiehW.J.UyekiT.M.et al.Myocardial injury and" exact="bacterial" post="pneumonia contribute to the pathogenesis of fatal influenza B"/>
 <result pre="influenza research prioritiesJ. Infect. Dis.201220587087210.1093/infdis/jir86522291194 22.PaddockC.D.LiuL.DenisonA.M.BartlettJ.H.HolmanR.C.Deleon-CarnesM.EmeryS.L.DrewC.P.ShiehW.J.UyekiT.M.et al.Myocardial injury and bacterial" exact="pneumonia" post="contribute to the pathogenesis of fatal influenza B virus"/>
 <result pre="pathogenesis of fatal influenza B virus infectionJ. Infect. Dis.201220589590510.1093/infdis/jir86122291193 23.ReedL.J.MuenchH.A" exact="Simple" post="Method of Estimating Fifty Per Cent Endpoints12Am. J. Epidemiol.19382749349710.1093/oxfordjournals.aje.a118408"/>
 <result pre="24.WuT.D.NacuS.Fast and SNP-tolerant detection of complex variants and splicing in" exact="short" post="readsBioinformatics20102687388110.1093/bioinformatics/btq05720147302 25.LiH.HandsakerB.WysokerA.FennellT.RuanJ.HomerN.MarthG.AbecasisG.DurbinR.The Sequence Alignment/Map format and SAMtoolsBioinformatics2009252078207910.1093/bioinformatics/btp35219505943 26.AndersS.PylP.T.HuberW.HTSeq—A Python"/>
 <result pre="quantitative PCR and the 2−∆∆Ct methodMethods20012540240810.1006/meth.2001.126211846609 32.ShengZ.LiuR.YuJ.RanZ.NewkirkS.J.AnW.LiF.WangD.Identification and characterization of" exact="viral" post="defective RNA genomes in influenza B virusJ. Gen. Virol.20189947548810.1099/jgv.0.00101829458654"/>
 <result pre="33.TissariJ.SirenJ.MeriS.JulkunenI.MatikainenS.IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and" exact="epithelial" post="cells by up-regulating TLR3 expressionJ. Immunol.20051744289429410.4049/jimmunol.174.7.428915778392 34.LiuT.ZhangL.JooD.SunS.-C.NF-κB signaling in"/>
 <result pre="Rev. Immunol.20141431532810.1038/nri366524762827 37.VerhelstJ.SpitaelsJ.NurnbergerC.De VliegerD.YsenbaertT.StaeheliP.FiersW.SaelensX.Functional Comparison of Mx1 from Two Different" exact="Mouse" post="Species Reveals the Involvement of Loop L4 in the"/>
 <result pre="38.VerhelstJ.ParthoensE.SchepensB.FiersW.SaelensX.Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional" exact="viral" post="ribonucleoprotein complex assemblyJ. Virol.201286134451345510.1128/JVI.01682-1223015724 39.KronckeK.D.FehselK.Kolb-BachofenV.Inducible nitric oxide synthase in"/>
 <result pre="40.BosworthA.DowallS.D.Garcia-DorivalI.RickettN.Y.BruceC.B.MatthewsD.A.FangY.AljabrW.KennyJ.NelsonC.et al.A comparison of host gene expression signatures associated with" exact="infection" post="in vitro by the Makona and Ecran (Mayinga) variants"/>
 <result pre="Paracrine Induction of Interferon Lambda 1J. Virol.201993e00559-1910.1128/JVI.00559-1931375585 42.CrottaS.DavidsonS.MahlakoivT.DesmetC.J.BuckwalterM.R.AlbertM.L.StaeheliP.WackA.Type I and" exact="Type III" post="Interferons Drive Redundant Amplification Loops to Induce a Transcriptional"/>
 <result pre="Influenza-Infected Airway EpitheliaPLoS Pathog.20139e100377310.1371/journal.ppat.100377324278020 43.RussellA.B.ElshinaE.KowalskyJ.R.te VelthuisA.J.W.BloomJ.D.Single-Cell Virus Sequencing of Influenza" exact="Infections" post="That Trigger Innate ImmunityJ. Virol.201993e00500-1910.1128/JVI.00500-1931068418 44.ChenF.ZhangC.JiaX.WangS.WangJ.ChenY.ZhaoJ.TianS.HanX.HanL.Transcriptome Profiles of Human"/>
 <result pre="Aspergillus fumigatus by RNA-SeqPLoS ONE201510e013572010.1371/journal.pone.013572026273834 45.LiuW.QiuX.SongC.SunY.MengC.LiaoY.TanL.DingZ.LiuX.DingC.Deep Sequencing-Based Transcriptome Profiling Reveals" exact="Avian" post="Interferon-Stimulated Genes and Provides Comprehensive Insight into Newcastle Disease"/>
 <result pre="Reveals Avian Interferon-Stimulated Genes and Provides Comprehensive Insight into Newcastle" exact="Disease" post="Virus-Induced Host ResponsesViruses20181016210.3390/v10040162 46.MakelaS.M.OsterlundP.WesteniusV.LatvalaS.DiamondM.S.GaleM.Jr.JulkunenI.RIG-I Signaling Is Essential for Influenza"/>
 <result pre="Insight into Newcastle Disease Virus-Induced Host ResponsesViruses20181016210.3390/v10040162 46.MakelaS.M.OsterlundP.WesteniusV.LatvalaS.DiamondM.S.GaleM.Jr.JulkunenI.RIG-I Signaling Is" exact="Essential" post="for Influenza B Virus-Induced Rapid Interferon Gene ExpressionJ. Virol.201589120141202510.1128/JVI.01576-1526378160"/>
 <result pre="ResponsesAdvances in ImmunologyAcademic PressCambridge, MA, USA2007964110117981204 49.BaggaS.BouchardM.J.Cell cycle regulation during" exact="viral" post="infectionMethods Mol. Biol.2014117016522724906315 50.LiL.GuB.ZhouF.ChiJ.FengD.XieF.WangF.MaC.LiM.WangJ.et al.Cell cycle perturbations induced by"/>
 <result pre="Biol.2014117016522724906315 50.LiL.GuB.ZhouF.ChiJ.FengD.XieF.WangF.MaC.LiM.WangJ.et al.Cell cycle perturbations induced by human herpesvirus 6" exact="infection" post="and their effect on virus replicationArch. Virol.201415936537010.1007/s00705-013-1826-024013234 51.DoveB.BrooksG.BicknellK.WurmT.HiscoxJ.A.Cell cycle"/>
 <result pre="effect on virus replicationArch. Virol.201415936537010.1007/s00705-013-1826-024013234 51.DoveB.BrooksG.BicknellK.WurmT.HiscoxJ.A.Cell cycle perturbations induced by" exact="infection" post="with the coronavirus infectious bronchitis virus and their effect"/>
 <result pre="Virol.201415936537010.1007/s00705-013-1826-024013234 51.DoveB.BrooksG.BicknellK.WurmT.HiscoxJ.A.Cell cycle perturbations induced by infection with the coronavirus" exact="infectious" post="bronchitis virus and their effect on virus replicationJ. Virol.2006804147415610.1128/JVI.80.8.4147-4156.200616571830"/>
 <result pre="51.DoveB.BrooksG.BicknellK.WurmT.HiscoxJ.A.Cell cycle perturbations induced by infection with the coronavirus infectious" exact="bronchitis" post="virus and their effect on virus replicationJ. Virol.2006804147415610.1128/JVI.80.8.4147-4156.200616571830 52.JiangW.WangQ.ChenS.GaoS.SongL.LiuP.HuangW.Influenza"/>
 <result pre="analysis was conducted using DESeq. (b) Gene expression Dynamics. A" exact="total" post="of 4365 genes showing changed expression at one or"/>
 <result pre="and included genes with significant expression level changes upon IBV" exact="infection" post="are shown below the bar graph. Each bar represents"/>
 <result pre="immune response (a–f): RIG-I, TLR3, IFN-λ2, IFN-λ3, IFNβ, and TNFα;" exact="viral" post="resistance (g,h): ISG15 and Mx1; autophagy (i): AMBRA1; and"/>
 <result pre="6.41 × 10−19 4917 Prolactin signaling pathway 16 0.00386 4940" exact="Type I" post="diabetes mellitus 12 0.0017 5133 Pertussis 30 4.58 ×"/>
 <result pre="10−19 4917 Prolactin signaling pathway 16 0.00386 4940 Type I" exact="diabetes mellitus" post="12 0.0017 5133 Pertussis 30 4.58 × 10−12 5134"/>
 <result pre="16 0.00386 4940 Type I diabetes mellitus 12 0.0017 5133" exact="Pertussis" post="30 4.58 × 10−12 5134 Legionellosis 23 2.73 ×"/>
 <result pre="mellitus 12 0.0017 5133 Pertussis 30 4.58 × 10−12 5134" exact="Legionellosis" post="23 2.73 × 10−09 5142 Chagas disease (American trypanosomiasis)"/>
 <result pre="4.58 × 10−12 5134 Legionellosis 23 2.73 × 10−09 5142" exact="Chagas disease" post="(American trypanosomiasis) 30 4.32 × 10−08 5143 African trypanosomiasis"/>
 <result pre="× 10−12 5134 Legionellosis 23 2.73 × 10−09 5142 Chagas" exact="disease" post="(American trypanosomiasis) 30 4.32 × 10−08 5143 African trypanosomiasis"/>
 <result pre="5142 Chagas disease (American trypanosomiasis) 30 4.32 × 10−08 5143" exact="African trypanosomiasis" post="11 0.00117 5144 Malaria 12 0.00552 5145 Toxoplasmosis 29"/>
 <result pre="Chagas disease (American trypanosomiasis) 30 4.32 × 10−08 5143 African" exact="trypanosomiasis" post="11 0.00117 5144 Malaria 12 0.00552 5145 Toxoplasmosis 29"/>
 <result pre="30 4.32 × 10−08 5143 African trypanosomiasis 11 0.00117 5144" exact="Malaria" post="12 0.00552 5145 Toxoplasmosis 29 4.72 × 10−06 5150"/>
 <result pre="5143 African trypanosomiasis 11 0.00117 5144 Malaria 12 0.00552 5145" exact="Toxoplasmosis" post="29 4.72 × 10−06 5150 Staphylococcus aureus infection 16"/>
 <result pre="0.00552 5145 Toxoplasmosis 29 4.72 × 10−06 5150 Staphylococcus aureus" exact="infection" post="16 0.000115 5160 Hepatitis C 36 3.12 × 10−08"/>
 <result pre="4.72 × 10−06 5150 Staphylococcus aureus infection 16 0.000115 5160" exact="Hepatitis" post="C 36 3.12 × 10−08 5161 Hepatitis B 37"/>
 <result pre="16 0.000115 5160 Hepatitis C 36 3.12 × 10−08 5161" exact="Hepatitis" post="B 37 8.17 × 10−08 5162 Measles 44 5.90"/>
 <result pre="10−13 5164 Influenza A 58 1.79 × 10−17 5166 HTLV-I" exact="infection" post="43 0.000802 5168 Herpes simplex infection 62 6.41 ×"/>
 <result pre="× 10−17 5166 HTLV-I infection 43 0.000802 5168 Herpes simplex" exact="infection" post="62 6.41 × 10−19 5169 Epstein–Barr virus infection 33"/>
 <result pre="0.000802 5168 Herpes simplex infection 62 6.41 × 10−19 5169" exact="Epstein–Barr virus infection" post="33 0.00296 5203 Viral carcinogenesis 45 2.64 × 10−08"/>
 <result pre="5168 Herpes simplex infection 62 6.41 × 10−19 5169 Epstein–Barr" exact="virus infection" post="33 0.00296 5203 Viral carcinogenesis 45 2.64 × 10−08"/>
 <result pre="Herpes simplex infection 62 6.41 × 10−19 5169 Epstein–Barr virus" exact="infection" post="33 0.00296 5203 Viral carcinogenesis 45 2.64 × 10−08"/>
 <result pre="6.41 × 10−19 5169 Epstein–Barr virus infection 33 0.00296 5203" exact="Viral" post="carcinogenesis 45 2.64 × 10−08 5320 Autoimmune thyroid disease"/>
 <result pre="33 0.00296 5203 Viral carcinogenesis 45 2.64 × 10−08 5320" exact="Autoimmune" post="thyroid disease 13 0.0032 5323 Rheumatoid arthritis 25 2.28"/>
 <result pre="0.00296 5203 Viral carcinogenesis 45 2.64 × 10−08 5320 Autoimmune" exact="thyroid disease" post="13 0.0032 5323 Rheumatoid arthritis 25 2.28 × 10−06"/>
 <result pre="5203 Viral carcinogenesis 45 2.64 × 10−08 5320 Autoimmune thyroid" exact="disease" post="13 0.0032 5323 Rheumatoid arthritis 25 2.28 × 10−06"/>
 <result pre="2.64 × 10−08 5320 Autoimmune thyroid disease 13 0.0032 5323" exact="Rheumatoid arthritis" post="25 2.28 × 10−06 5330 Allograft rejection 10 0.00542"/>
 <result pre="× 10−08 5320 Autoimmune thyroid disease 13 0.0032 5323 Rheumatoid" exact="arthritis" post="25 2.28 × 10−06 5330 Allograft rejection 10 0.00542"/>
 <result pre="2.28 × 10−06 5330 Allograft rejection 10 0.00542 5332 Graft-versus-host" exact="disease" post="11 0.00245 5416 Viral myocarditis 13 0.00893 viruses-12-00383-t002_Table 2Table"/>
 <result pre="Allograft rejection 10 0.00542 5332 Graft-versus-host disease 11 0.00245 5416" exact="Viral" post="myocarditis 13 0.00893 viruses-12-00383-t002_Table 2Table 2 KEGG pathways significantly"/>
 <result pre="rejection 10 0.00542 5332 Graft-versus-host disease 11 0.00245 5416 Viral" exact="myocarditis" post="13 0.00893 viruses-12-00383-t002_Table 2Table 2 KEGG pathways significantly enriched"/>
 <result pre="Metabolic pathways 134 2.40 × 10−07 24 hpi 3460 Fanconi" exact="anemia" post="pathway 17 2.40 × 10−06 24 hpi 4110 Cell"/>
</results>
